Active ingredients:

Cefazolin as sterile cefazolin sodium - 500 mg or 1000 mg.

CEFAZOLIN-BCPP is a semi-synthetic first generation cephalosporin antibiotic for paranteral administration. It has a broad-spectrum action against some gram-positive and gram-negative microorganisms. It is active against strains resistant to penicillin, streptomycin, and sulfanilamides.

Indications

CEFAZOLIN-BCPP is indicated for the treatment of infections caused by CEFAZOLIN-susceptible microorganisms:

• respiratory tract infections,
• urogenital infections;
• skin and soft tissue infections;
• bile duct infections;
• bone and joint infections;
• endocarditis;
• sepsis;
• prevention of postoperative infections.

Dosage and pharmaceutical form:

powder  for solution for injection 500 mg or 1000 mg, in vials; No.1 vial with powder; 1 vial together with 1 ampoule of solvent (water for injection) 5 ml (for dosage 500 mg or 1000 mg) or 10 ml (for dosage 1000 mg) in package; No.1 vial per package.